DataLase and Colorcon Inc. Sign Licensing Agreement to Develop DataLase PHARMAMARK

Steve Kelly, CEO of DataLase, added,“We are delighted to be able to develop this innovative new technology, and are committed to working in partnership with industry experts at Colorcon to bring DataLase PHARMAMARK to these markets over the coming year. Patents for the technology have already been granted in the US and key European countries.”